| Phase 11 trial |
|
Phase 1
|
NCT07206043 |
Dec 2024 → Feb 2025 |
— |
R-Pharm International, LLC |
Completed
|
No outcome recorded
|
| Phase 25 trials |
|
Phase 2
|
NCT04213274 |
May → Aug 2023 |
Schnitzler syndrome |
R-Pharm Overseas, Inc. |
Withdrawn
|
No outcome recorded
|
|
Phase 2
|
NCT05190991 |
Oct 2021 → Dec 2028 expected |
familial Mediterranean fever |
R-Pharm International, LLC |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT05092776 |
Apr 2021 → Jan 2025 overdue |
familial Mediterranean fever |
R-Pharm International, LLC |
Active not recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT04463251 |
Dec 2020 → Nov 2021 |
ST-elevation myocardial infarction |
R-Pharm Overseas, Inc. |
Completed
|
No outcome recorded
|
|
Phase 2
|
NCT04067492 |
Mar 2018 → Mar 2020 |
gout |
R-Pharm |
Terminated
|
No outcome recorded
|
| Phase 2/33 trials |
|
Phase 2/3
|
NCT05107934 |
Dec 2025 → May 2027 |
pericarditis |
R-Pharm Overseas, Inc. |
Suspended
|
No outcome recorded
|
|
Phase 2/3
|
NCT04380519 |
Apr → Jul 2020 |
COVID-19 |
R-Pharm International, LLC |
Completed
|
No outcome recorded
|
|
Phase 2/3
|
NCT04692766 |
Feb 2020 → Jan 2022 |
idiopathic recurrent pericarditis |
R-Pharm International, LLC |
Completed
|
No outcome recorded
|
| Phase 33 trials |
|
Phase 3
|
NCT07625384 |
May 2026 → Dec 2027 expected |
— |
R-Pharm International, LLC |
Not yet recruiting
|
No outcome recorded
|
|
Phase 3
|
NCT05432960 |
Dec 2023 → Aug 2025 |
adult-onset Still disease |
R-Pharm International, LLC |
Withdrawn
|
No outcome recorded
|
|
Phase 3
|
NCT05673902 |
Dec 2020 → Jan 2026 overdue |
idiopathic recurrent pericarditis |
R-Pharm International, LLC |
Active not recruiting
|
No outcome recorded
|